Published in Arch Pathol Lab Med on December 01, 1977
Clinical and pathological study of asymptomatic HBsAg carriers in Chile. Gut (1978) 0.82
Natural history of the HBsAg carrier. Gut (1985) 0.79
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79
Prevalence of non-A,non-B hepatitis/hepatitis C virus antibody in human immunoglobulins. Am J Clin Pathol (1992) 2.12
Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group. Gastroenterology (1993) 2.03
Electron microscopic studies of viral agents in Crohn's disease. Lancet (1976) 1.43
Cultivation of viral agents from Crohn's disease. A new sensitive system. Lancet (1976) 1.42
Hepatitis-associated antigen screening by automated complement fixation: comparison with manual methods. Am J Clin Pathol (1973) 1.37
Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen. Gut (1976) 1.35
Detection of long-lasting antibody to hepatitis E virus in a US traveller to Pakistan. Lancet (1992) 1.29
An improved diluent for rubella hemagglutination and hemagglutination-inhibition tests. Appl Microbiol (1968) 1.28
Viral investigations in ulcerative colitis and regional enteritis. Gastroenterology (1973) 1.27
Limitations of solid-phase radioimmunoassay for hb ag in reducing frequency of post-transfusion hepatitis. N Engl J Med (1973) 1.23
Cricopharyngeal myotomy: management of cervical dysphagia. Otolaryngol Head Neck Surg (1983) 1.20
Behaviour of e antigen and antibody during chronic active liver disease. Relation to HB antigen-antibody system and prognosis. Lancet (1976) 1.20
Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis (1978) 1.05
Australia antigen in chronic active liver disease with cirrhosis. Lancet (1969) 1.02
Non-A, non-B hepatitis transmission in chimpanzees: a project of the transfusion-transmitted viruses study group. Intervirology (1978) 1.00
The long-term course of non-A, non-B post-transfusion hepatitis. Gastroenterology (1980) 0.98
Hepatitis B vaccine: low postvaccination immunity in hospital personnel given gluteal injections. Hepatology (1985) 0.96
Post-transfusion chronic liver disease. Gastroenterology (1976) 0.96
Non-A, non-B posttransfusion hepatitis--a decade later. Gastroenterology (1985) 0.93
Prevention of post-transfusion hepatitis. Role of sensitive hepatitis B antigen screening tests, source of blood and volume of transfusion. Am J Med (1975) 0.93
Post-transfusion hepatitis in recipients of blood screened by newer assays. Lancet (1973) 0.93
CEA levels in fluids bathing gastrointestinal tumors. Gastroenterology (1976) 0.92
Androgenic steroids and hepatocellular carcinoma. Lancet (1973) 0.92
Immunosuppressive activity of concanavalin A. Science (1969) 0.90
Experimental acute and chronic viral hepatitis. Effect of antithymocyte globulin. Gastroenterology (1970) 0.89
Spironolactone bodies in an adrenal adenoma. Arch Pathol (1975) 0.89
Hypernatremia after the administration of lactulose. Ann Intern Med (1977) 0.89
Evidence for the isolation of a new virus from ulcerative colitis patients. Comparison with virus derived from Crohn's disease. Dig Dis Sci (1979) 0.89
Correlation between fluorescent antibody detection of hepatitis B core antigen in liver biopsies and the presence of e antigen in serum. Infect Immun (1976) 0.87
Anticomplementary hepatitis B antigen. Prognostic importance in chronic active liver disease. Arch Intern Med (1973) 0.86
Anticore antibody screening of transfused blood. Vox Sang (1978) 0.86
Clinical and pathologic findings of the liver in the acquired immune deficiency syndrome (AIDS). Am J Clin Pathol (1985) 0.85
The electronic video endoscope: clinical experience with 1200 diagnostic and therapeutic cases in the community hospital. Gastrointest Endosc (1987) 0.85
Rubella virus: continuous and concurrent production of complement-fixing antigen and infectious virus in suspension cultures. Appl Microbiol (1967) 0.85
Aetiological theories of inflammatory bowel disease. Clin Gastroenterol (1980) 0.85
Cultivation of rubella virus in avian tissue cultures and embryonated eggs. Proc Soc Exp Biol Med (1967) 0.83
Vigorous medical management of acute fulminant hepatitis. Arch Intern Med (1977) 0.83
Chronic active hepatitis. Who meets treatment criteria? Dig Dis Sci (1980) 0.82
Hepatitis B surface antigen carriers--to biopsy or not to biopsy. Gastroenterology (1978) 0.81
Hepatitis-associated antigen in selected mothers and newborn infants. J Pediatr (1972) 0.80
Studies of the "e" antigen in acute and chronic hepatitis. Gastroenterology (1976) 0.79
Viral hepatitis. West J Med (1978) 0.79
Drug therapy of acute pancreatitis. Clin Gastroenterol (1979) 0.78
Shigella hepatitis. JAMA (1976) 0.78
Histological response and antigen transmission in the lymph nodes of athymic nu/nu mice inoculated with Crohn's disease tissue filtrates. Gut (1988) 0.78
A serological survey for Australia antigen and antibody. Am J Dis Child (1971) 0.78
Chronic active hepatitis of hepatitis B and non-A, non-B etiology. Am J Surg Pathol (1982) 0.78
Missing pieces in the puzzle of Crohn's disease. Gastroenterology (1978) 0.78
A histologic comparison of hepatitis B with non-A, non-B chronic active hepatitis. Arch Pathol Lab Med (1982) 0.77
Maternal and neonatal Australia antigen. Calif Med (1971) 0.77
Acute fulminant hepatitis. A clustering of cases. Arch Intern Med (1974) 0.76
Australia antigen and the revolution in hepatology. Calif Med (1972) 0.75
Chronic rubella virus infection in the ferret (Mustela putorius fero) puppy. Proc Soc Exp Biol Med (1967) 0.75
HBe-Antigen in the course and prognosis of hepatitis B infection: a prospective study. Gastroenterology (1980) 0.75
Eradication of hepatitis B antigen in fulminant hepatitis. West J Med (1974) 0.75
Production of rubella hemagglutinating antigen in suspension cultures. Appl Microbiol (1967) 0.75
The significance of australia antigen. Calif Med (1973) 0.75
Automated continuous-flow hemagglutination inhibition test for hepatitis B antigen in blood. Vox Sang (1973) 0.75
Letter: Transmission of carcinoembryonic antigen by transfused blood. Lancet (1974) 0.75
Comparison of Hepa-Gent and hepatitis associated antigen as determinants of liver disease. Am J Med Technol (1973) 0.75
Hepatitis B antigen: new technics for the reduction of posttransfusion hepatitis. Am J Gastroenterol (1974) 0.75
Experience with endomyocardial biopsy in 23 patients with heart transplants. J Okla State Med Assoc (1989) 0.75
Rubella virus complement-fixing antigen: sedimentable and non-sedimentable antigenic components. Proc Soc Exp Biol Med (1967) 0.75
Transplantation of hepatitis B surface antigen positive bone marrow. Transfusion (1978) 0.75
Prevalence of non-A, non-B hepatitis/hepatitis C virus antibody in laboratory quality-assurance sera. Clin Chem (1991) 0.75
Naturally occurring antibody against unusually high serum DNA polymerase activity. Nature (1976) 0.75
Cold sterilization techniques and hepatitis B. West J Med (1979) 0.75
Case report: Diarrhea syndrome in hepatic adenoma. Am J Dig Dis (1975) 0.75
Oral administration of attenuated rubella virus vaccine (HPV-77). A negative report. J Pediatr (1968) 0.75
Chronic active hepatitis: are prognostic markers prognostic? Gastroenterology (1978) 0.75
Rubella neutralizing antibody determinations with the rabbit kidney cell strain LLC-RK. Proc Soc Exp Biol Med (1968) 0.75
Carcinoembryonic antigen: transmission by blood products. Cancer (1978) 0.75
Post-transfusion hepatitis: the role of hepatitis B antibody. Gastroenterology (1976) 0.75
The Arias Stella reaction. A case report of a cytologic presentation. Acta Cytol (1977) 0.75
Etiology of inflammatory bowel diseases: are we making progress? Gastroenterology (1980) 0.75
Post-transfusion hepatitis: analysis of risk factors. Acta Haematol Pol (1981) 0.75
The liver and the antigens of hepatitis B. Ann Intern Med (1976) 0.75
Problems in the detection of rubella virus in African green monkey kidney tissue culture. Proc Soc Exp Biol Med (1968) 0.75
Clinical value of serum bile acid levels in chronic hepatitis. Dig Dis Sci (1981) 0.75
Hepatitis B virus infection in dental students. A two-year evaluation. J Oral Med (1979) 0.75